Newcastle spin-out creating more and better jobs

Dr Jennifer Munkley academic founder of GlycoScoreDX

Newcastle University spin-out GlycoScoreDX is recruiting a Research Technician based in Newcastle, as the company continues to develop and expand, creating high quality jobs in the North East.  GlycoScoreDx aims to transform the future of prostate cancer diagnosis, through the spin-out company  founded upon research by Dr Jennifer Munkley and her research group.  Find out […]

Newcastle University spin-out GlycoScoreDX raises £1m seed funding

North East-based diagnostics company and Newcastle University spin-out, GlycoScoreDx, has secured £630,000 in equity funding alongside an additional £360,000 in grant funding to support business establishment and early development of its proprietary Prostate Cancer test. The GlycoScore Prostate Cancer test is a simple, reliable blood test which can be used to accurately diagnose and risk-assess […]

CellulaREvolution raises £1m to further accelerate the development of lab grown cells

Technology disrupter CellulaREvolution, which aims to revolutionise the way cells are grown in labs, has raised £1million from a set of strategic investors including CPT Capital, Stephan Schmidt, Orange Light Ventures, and funds managed by Northstar Ventures, the North East Innovation Fund supported by the European Regional Development Fund and the newly launched Northern Accelerator […]

3D Bio-Tissues moves into specialist lab facility at The Biosphere on Newcastle Helix

Another Northern Accelerator spin-out from Newcastle University is making its home at The Biosphere on Newcastle Helix, joining a growing cluster of life science businesses. 3D Bio-Tissues aims to tackle donor shortages and speed up life-changing transplants worldwide, specialising in creating ‘bio-equivalent’ structural tissues. Dr Che Connon, co-founder and CEO of 3D Bio-Tissues said: “The […]

Newcastle University spin-out joins The Biosphere at Newcastle Helix

Newcastle University spin-out, AMLo Biosciences, has moved to The Biosphere, a specialist lab facility on Newcastle Helix. The ground-breaking cancer diagnostics firm, formed in 2017, looks to save up to 2,000 lives each year with their prognostic test for early-stage skin cancer. The company’s first product (AMBLor) will go to market in 2021, launching in […]

Newcastle University spin-out strengthens leadership team

Three years after spinning out from Newcastle University as the first Northern Accelerator supported spin-out, Atelerix has announced a significant further strengthening of its leadership team. Two experienced industry executives will help lead Atelerix in implementing its strategy to provide room temperature solutions for the shipping of therapeutic cells in the fast growing cellular therapy […]

Newcastle spin-out 3D Bio-Tissues closes second investment round

Newcastle University spin-out, 3D Bio-Tissues, creators of an innovative tissue engineering technology, has closed a second round of funding of £420,000 to accelerate development of its tissue engineered products to market. 3D Bio-Tissues has identified a significant and unique commercial opportunity in the rapidly developing 3D tissue technology area, where it aims to offer superior […]